title: [Novartis should discontinue its patent case in India!].
authors: pehrolov.person@hotmail.com
authors: Pehrson
authors: P
authors: PehrOlov
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics; D001549:Benzamides; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D006801:Humans; D000068877:Imatinib Mesylate; D007194:India; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D010879:Piperazines / Q000191:economics; D011743:Pyrimidines / Q000191:economics
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate